Skip to main navigation Skip to search Skip to main content

White-matter changes on MRI as surrogate marker

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

This article reviews the use of white-matter changes as identified on MRI as a surrogate marker in clinical trials on vascular dementia. As of yet, insufficient evidence is present to implement rating or volumetric assessment of the burden of white-matter changes as surrogate marker in such trials, in view of the limited sensitivity to change of current methods and the high measurement error.

Original languageEnglish
Pages (from-to)261-265
Number of pages5
JournalInternational Psychogeriatrics
Volume15
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 7 Oct 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Clinical trials
  • Dementia
  • MRI
  • pH
  • Vascular
  • White matter

Fingerprint

Dive into the research topics of 'White-matter changes on MRI as surrogate marker'. Together they form a unique fingerprint.

Cite this